China’s self-driving cars need to adapt to EU tech compliance regulations | Winning bids for drug procurement contracts to be kept confidential as regulators aim to balance competition and sustainability | China adds U.S.-linked ETFs in latest expansion of cross-border ETF Connect program
Forced tech transfers are a possible precondition for Chinese firms in Europe. | China closes unclarified aspects of the cross-border data transfer regime. | Over RMB 11 million in penalties signal banking regulators’ focus on data security and risk control.
Ministry of Commerce requires permits for export of rare earth. Network-related companies are required to report any cybersecurity incidents.
Increase in venture capital into China marks recovery of sector | U.S. state attorneys general target TP-Link, Lorex and Temu in widening push over privacy and security | China’s investments into Central Asia create integrated economic ecosystems
New enterprise bankruptcy draft deals with cross-border bankruptcy cases. SPC specifies invalid amendments of articles of association. Trust companies’ scope of business is changed.
U.S. export controls extended to subsidiaries of Chinese companies | PBOC broadens foreign access to its bond market by aligning China’s repo framework with global standards | U.S. court rules that DJI failed to counter proof of its military links.
China allows QFIIs to engage in bond repos. Practical guidelines define various AI security emergencies. Large online platforms are required to set up committees to protect personal information.
Eight landmark AI judgments set precedents on AI-related infringement. | China attempts to displace the U.S. and Germany in determining industry standards. | Increased foreign interest in Chinese stocks adds US$3 trillion to market.
Registration of the basic particulars of the upfront expenses in domestic direct investments is abolished. IP transfer and appraisal might involve national security compliance. Accounting firms could be required to take enhanced client due diligence measures.
U.S. pharma raises alarm over Trump’s proposed measures against Chinese drugs; China clarifies the type of employees to be bound by non-compete clauses; and Some stablecoin issuers complain that Hong Kong’s regime is too stringent.
